aTyr Pharma Inc (LIFE.OQ) Insider Trading | Reuters.com
Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

2.66USD
11:03am EDT
Change (% chg)

$0.10 (+3.91%)
Prev Close
$2.56
Open
$2.65
Day's High
$2.69
Day's Low
$2.53
Volume
13,203
Avg. Vol
66,071
52-wk High
$21.00
52-wk Low
$2.53

LORIMIER BRADLEY G

Institutional Holders

% Shares Owned: 91.20%
# of Holders: 80
Total Shares Held: 21,602,514
3 Mo. Net Change: -289,496
# New Positions: 13
# Closed Positions: 10
# Increased Positions: 34
# Reduced Positions: 33
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

John Mendlein

56 2011 Chief Executive Officer and Executive Chairman, Board of Directors

John Clarke

62 2005 Non-Executive Independent Chairman of the Board

John Blake

39 2016 Principal Financial Officer, Chief Accounting Officer

Melissa Ashlock

57 2011 Vice President - External Scientific Alliances and Human Genetics

Kelly Blackburn

51 2013 Vice President - Clinical Affairs

Holly Chrzanowski

49 2013 Vice President - Enterprise Talent and Organization

Andrew Cubitt

52 2011 Vice President - Product Protection

John McKew

51 2014 Vice President - Research

Fred Ramsdell

54 2014 Vice President - Immunology

Sanuj Ravindran

2016 Chief Business Officer

Sanjay Shukla

2016 Chief Medical Officer

Srinivas Akkaraju

47 2015 Non-Executive Independent Director

James Blair

75 2010 Non-Executive Independent Director

Kathryn Falberg

55 2014 Non-Executive Independent Director

Mark Goldberg

61 2015 Non-Executive Independent Director

Amir Nashat

37 2006 Non-Executive Independent Director

Paul Schimmel

75 2005 Non-Executive Independent Director